Furthermore, we introduced two modified versions of the model to address specific considerations: one disregarding the impact of type 2 diabetes by assuming a constant insulin concentration, and another reducing the activation rate of microglia. The gene discussed is INS; the disease is type 2 diabetes mellitus.